ASX:ALX Atlas Arteria (ALX) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Atlas Arteria Stock (ASX:ALX) Get Atlas Arteria alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume3.69 million shsAverage VolumeN/AMarket CapitalizationA$7.33 billionP/E Ratio31.31Dividend Yield7.92%Price TargetN/AConsensus RatingN/A Company Overview Atlas Arteria Limited owns, develops, and operates toll roads. It holds a 31.14% of interest in the APRR and A79 and 31.17% interest in the ADELAC located in France; 100% interest in the Warnow Tunnel located in Rostock, Germany; 66.67% interest in the Chicago Skyway situated in Chicago and 100% interest in the Dulles Greenway located in Virginia, United States. The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. Atlas Arteria Limited was incorporated in 2009 and is based in Melbourne, Australia. Read More Receive ALX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Atlas Arteria and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ALX Stock News HeadlinesAtlas Arteria Limited (ASX:ALX) is largely controlled by institutional shareholders who own 77% of the companyAugust 20, 2025 | finance.yahoo.comWhy Macquarie expects this high-yielding ASX 200 dividend stock to outperformJuly 31, 2025 | msn.comCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure. SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation.September 18 at 2:00 AM | SmartAsset (Ad)Atlas Arteria retreats after US toll rates setbackJuly 19, 2025 | msn.comWhy 29Metals, Atlas Arteria, DroneShield, and Yancoal shares are falling todayJuly 18, 2025 | msn.comAtlas Arteria Stock Price History - Investing.comJune 26, 2025 | investing.comAtlas Arteria records 6.1% jump in Q1 toll revenueApril 23, 2025 | msn.comASX Market Close: Index pares gains to close flat | March 25, 2025March 25, 2025 | msn.comSee More Headlines ALX Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Atlas Arteria own? Based on aggregate information from My MarketBeat watchlists, some other companies that Atlas Arteria investors own include Adairs (ADH), AMA Group (AMA), ANZ Group (ANZ), Commonwealth Bank of Australia (CBA), Fortescue (FMG), Gilead Sciences (GILD) and Industry, Sector and Symbol Stock ExchangeASX SectorIndustrials Industry Infrastructure Operations Sub-IndustryTrading Current SymbolASX:ALX CIKN/A Webwww.atlasarteria.com Phone61 2 8232 7455FaxN/AEmployees70Year FoundedN/AProfitability EPS (Trailing Twelve Months)A$0.21 Trailing P/E Ratio31.31 Forward P/E RatioN/A P/E Growth0.31Net IncomeA$300.20 million Net Margins167.02% Pretax MarginN/A Return on Equity3.79% Return on Assets-0.06% Debt Debt-to-Equity Ratio27.23 Current Ratio2.26 Quick Ratio1.77 Sales & Book Value Annual SalesA$140.10 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow3.65 Book ValueA$4.21 per share Price / BookN/AMiscellaneous Outstanding Shares1,450,000,000Free FloatN/AMarket CapA$7.33 billion OptionableNot Optionable Beta0.78 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (ASX:ALX) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atlas Arteria Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Atlas Arteria With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.